GenScript, a biotechnology company, has announced the commercial launch of its neoantigen peptide synthesis service for biotech and pharma companies developing personalized cancer therapeutics. The ...

Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Instruments (Peptide Synthesizer, Chromatography, Lyophilizer), Technique (Solid-Phase, ...

GenScript is best known for its gene synthesis capabilities, which we estimate is more than half of the life science services and products segment. In 2014, GenScript was the leader in gene synthesis, ...

GenScript Biotech Corporation (“GenScript”, Stock Code: 1548.HK) receives the “Best Contract Research Organization Award” on the 4th Annual Asia Pacific Bioprocessing Excellence Awards Ceremony 2021 ...

GenScript Biotech Corporation, a global leader in life science research tools and services, has announced the expansion of its in vitro transcription (IVT) RNA synthesis portfolio to include ...